Non-Immune Hydrops Fetalis: Management and Outcomes
Keywords:
non-immune hydrops fetalis, immunoglobulin therapy, fetal arrhythmias, paracentesis, thoracocentesis, cordocentesis, amnioreductionAbstract
The rapid development of fetal surgery has become possible thanks to modern online visualization systems, improvement of tools and equipment that allow penetrating into the special world of intrauterine development without consequences. One of the antenatal pathologies of the fetus that requires such high-tech minimally invasive methods of fetal treatment is non-immune fetal hydrops. This article discusses various aspects of non-immune fetal hydrops, including etiology, clinical picture, antenatal diagnosis and treatment tactics, and also provides some data on cases of non-immune fetal hydrops treated in the fetal medicine department of the Republican Specialized Scientific and Practical Medical Center for Maternal and Child Health.
References
Berghella V. (2017). Maternal-Fetal Evidence Based Guidelines. Boca Raton: CRC Press.
Ota S, Sahara J, Mabuchi A, Yamamoto R, Ishii K, Mitsuda N. Perinatal and one-year outcomes of non-immune hydrops fetalis by etiology and age at diagnosis. J Obstet Gynaecol Res. 2016;42(4):385-391. doi:10.1111/jog.12922
Pulatova GA, Yusupbaev RB. Diagnosis, Management and Outcomes of Non-Immune Hydrops Fetalis in Uzbekistan. American Journal of Medicine and Medical Sciences, Vol. 13 No. 2, 2023, pp. 170-175. doi: 10.5923/j.ajmms.20231302.30.
Бец ОГ, Хмелевская ИГ, Серёжкина АВ, Булка АА, Ходулапова ЛГ, Являнская ОС. Клинический случай неиммунной водянки у недоношенного ребенка с наличием IgG к SARS-СоV-2 при рождении. Человек и его здоровье. 2022;25(2):4-12. DOI:
21626/vestnik/2022-2/01
